Perceived Resilience and Vulnerability during the Pandemic-Infused Panic Buying and the Role of COVID Conspiracy Beliefs. Evidence from Pakistan.

Autor: Razzak, Ali¹ (AUTHOR), Yousaf, Salman² (AUTHOR)

Publikováno v: Journal of Global Marketing. Nov/Dec2022, Vol. 35 Issue 5, p368-383. 16p. 2 Diagrams, 6 Charts, 2 Graphs.

The Effect of the Alternative Evaluation Strategy on the Divergent Thinking of the Fourth Scientific Class Female Students in a Subject of Biology.

Autor: Ajil, Zainab Razzak Ali, Al-Afoun, Nadia Hussein Younis

Publikováno v: Special Education; 2022, Vol. 1 Issue 43, p7731-7746, 16p

Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology.

Autor: Tamborero D; Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden. david.tamborero@ki.se., Dienstmann R; Medical Oncology, Oncology Data Science, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Rachid MH; Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden., Boekel J; Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden., Lopez-Fernandez A; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Jonsson M; Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden., Razzak A; Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden., Braña I; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., De Petris L; Department of Oncology and Pathology, Karolinska Institutet, Theme Cancer, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden., Yachnin J; Department of Oncology and Pathology, Karolinska Institutet, Theme Cancer, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden., Baird RD; Cancer Research UK Cambridge Centre, Cambridge, UK., Loriot Y; Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Massard C; Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Martin-Romano P; Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Opdam F; The Netherlands Cancer Institute, Amsterdam, the Netherlands., Schlenk RF; NCT Trial Center, German Cancer Research Center, Heidelberg University Hospital, Heidelberg, Germany., Vernieri C; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; IFOM, FIRC Institute of Molecular Oncology, Milan, Italy., Masucci M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Villalobos X; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Chavarria E; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Balmaña J; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Apolone G; Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Caldas C; Cancer Research UK Cambridge Centre, Cambridge, UK., Bergh J; Department of Oncology and Pathology, Karolinska Institutet, Theme Cancer, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden., Ernberg I; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Fröhling S; National Center for Tumor Diseases Heidelberg, German Cancer Research Center, Heidelberg, Germany., Garralda E; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Karlsson C; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden., Tabernero J; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Voest E; The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Rodon J; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lehtiö J; Clinical Proteomics Unit, Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Karolinska University Hospital, Stockholm, Sweden. janne.lehtio@ki.se.

Publikováno v: Nature cancer [Nat Cancer] 2022 May; Vol. 3 (5), pp. 649.